Moreover, the enrichment of the TIGIT-NECTIN immune checkpoint and angiogenesis signaling pathways in different cell types in the TME of H. pylori infection-associated GC implies that the potential combination of immunotherapies and anti-angiogenic targeted therapeutic modalities could be an effective therapeutic approach for H. pylori infection-associated GC. Here, NECTIN1 is linked to gastric cancer.